World's 1st transplant surgery using iPS cells conducted

World's 1st transplant surgery using iPS cells conducted

KOBE, Japan - Photo taken Sept. 10, 2014, shows the Institute of Biomedical Research and Innovation Hospital in Kobe, western Japan. At the hospital on Sept. 12, a Japanese research team transplanted retinal cells grown from induced pluripotent stem cells to a woman in her 70s, marking the first time iPS-derived cells have been introduced into a human body by surgery. (Kyodo)

  • Product Code
  • ILEA000336190
  • Registered date
  • 2014/9/12 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • Media size
  • 3968 × 2293 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 1.01(MB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

    CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

    (240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui attends a video conference on his way to a branch office of Vivolight in Xi'an, northwest China's Shaanxi Province, Jan. 18, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascular surgery. In 2012,
      CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

      CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

      (240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui (R) talks with his colleague at a branch office of Vivolight in Xi'an, northwest China's Shaanxi Province, Jan. 19, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascular surgery. In 2012, he gave u
        CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

        CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

        (240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui (R) talks with his partner Dr. Mi Lei in Xi'an, northwest China's Shaanxi Province, Jan. 19, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascular surgery. In 2012, he gave up his doctoral studies
          CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

          CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

          (240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui (R) tests a new generation of OCT equipment at a laboratory of a branch office of Vivolight in Xi'an, northwest China's Shaanxi Province, Jan. 18, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascu
            CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

            CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

            (240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui (R) learns about the use of OCT equipment at Beijing Anzhen Hospital in Beijing, capital of China, Feb. 18, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascular surgery. In 2012, he gave up his do
              CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

              CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

              (240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui and his colleagues discuss the research progress of OCT technology at a laboratory of a branch office of Vivolight in Xi'an, northwest China's Shaanxi Province, Jan. 18, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT te
                CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

                CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

                (240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui adjusts equipment at a laboratory of Institute of Physics of the Chinese Academy of Sciences in Beijing, capital of China, Jan. 12, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascular surgery. In
                  CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

                  CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

                  (240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui (L) talks with a doctor about the use of OCT equipment at Beijing Anzhen Hospital in Beijing, capital of China, Feb. 18, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascular surgery. In 2012, he g
                    CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

                    CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

                    (240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui attends a video conference with experts at a branch office of Vivolight in Xi'an, northwest China's Shaanxi Province, Jan. 19, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascular surgery. In 2012
                      CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

                      CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

                      (240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui (back) observes doctors using OCT equipment at Beijing Anzhen Hospital in Beijing, capital of China, Feb. 18, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascular surgery. In 2012, he gave up his